Quest PharmaTech (CVE:QPT) Stock Price Down 25% – Here’s What Happened

Shares of Quest PharmaTech Inc. (CVE:QPT) were down 25% during mid-day trading on Thursday . The stock traded as low as C$0.03 and last traded at C$0.03. Approximately 123,238 shares traded hands during mid-day trading, an increase of 414% from the average daily volume of 23,982 shares. The stock had previously closed at C$0.04.

Quest PharmaTech Trading Down 25.0%

The company has a debt-to-equity ratio of 4.35, a quick ratio of 0.52 and a current ratio of 0.40. The stock has a market capitalization of C$5.07 million, a P/E ratio of -30.00 and a beta of 0.00. The firm’s fifty day simple moving average is C$0.04 and its 200 day simple moving average is C$0.04.

About Quest PharmaTech

Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class.